Pivotal bioVenture Partners Fund I, L.P., Director at Inozyme Pharma, Inc. (INZY), bought 952,381 shares at $4.80 ($4.6M) on 2023-08-01, disclosed to the SEC on 2023-08-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.80 | 119,048 | $571K | 12.5% |
| 2 | $4.80 | 119,048 | $571K | 12.5% |
| 3 | $4.80 | 714,285 | $3.4M | 75.0% |
| Total | $4.80 avg | 952,381 | $4.6M | 100% |